The acquisition of Signet significantly strengthens IMCD’s presence in India and increases IMCD’s position in the high-growth APAC region
In Q2, the company's net profit grew 177% YoY and reached Rs.172.75 crores
The company's revenues dropped by 5.51% YoY and reached Rs.696.68 crores in the second quarter
Company reported 18.58% increase in Q2 sales and the revenues reached Rs. 2459.73 crore
The company's revenue grew by 20% YoY and stood at Rs 1,418.47 crore
In Q2, the company's sales dropped marginally by 1.77% YoY and stood at Rs.274.89 crores
Company is making significant investments in both capital and resources to strengthen strategic capabilities of its Liveo brand healthcare silicone solutions
The total cost of the project will be about Rs. 230 crores and the plant is expected to be operational by March 2022
Acquisition of SkinInVitro GmbH is an important step towards the worldwide use and distribution of alternative test methods
The new Expancel Extra Small Microsphere (XSMS) line brings additional benefits to specialty thin coatings applications, such as improving the printability of thermal paper labels, tickets and receipts, as well as filling and upgrading genuine or artificial leather without sacrificing volume.
The company plans to use majority of this fund towards completion of front-end engineering design (FEED) optimisation program at the Company’s 100% owned Lake Wells Sulphate of Potash Project (LSOP) in Western Australia
Lummus' scope includes engineering and supply of the company's proprietary Short Residence Time (SRT) VI cracking furnaces.
Operating cash flow of $1.3 billion included improvements in working capital of more than $300 million in the quarter which was driven by lower inventories
ICN's e-conference on 06th November 2020 will see participation from leading R&D focused institutions and industry majors as speakers and delegates
After a detailed examination, the DGTR concluded that the product under consideration is likely to be dumped in significant volumes in the event of expiry of duty
The company has reported a jump of 67% YoY with a total income of Rs. 58.55 crores
Company expects to commence manufacturing of Ethylamines by the end of this financial year
The capital expenditure during the half year ended 30th September, 2020 was Rs. 62 crore.
During the quarter ended Sep 2020, the company's consolidated total income stood at Rs. 4,620 crores as against Rs. 4,867 crores last year
Company's revenue from operations grew by 15% and stood at Rs 9,014 crore as against Rs 7,841 crore in the same period last year.
Subscribe To Our Newsletter & Stay Updated
